Management of anterior chamber dislocation of a dexamethasone intravitreal implant: a case report

BACKGROUND: Ozurdex is a 700 mcg dexamethasone intravitreal implant, approved for the management of macular edema secondary to retinal vein occlusion, and other related pathoglogiesAnterior chamber dislocation of Ozurdex represents an uncommon complication of the intravitreal injection, which can be...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Med Case Rep
Prif Awduron: Pacella, Fernanda, Agostinelli, Enzo, Carlesimo, Sandra Cinzia, Nebbioso, Marcella, Secondi, Roberto, Forastiere, Michele, Pacella, Elena
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: BioMed Central 2016
Pynciau:
Case Report
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5062904/
https://ncbi.nlm.nih.gov/pubmed/27733187
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13256-016-1077-2
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg